Recipes for the Selection of Experimental Protein Conformations for Virtual Screening
暂无分享,去创建一个
Ruben Abagyan | Manuel Rueda | Giovanni Bottegoni | R. Abagyan | G. Bottegoni | M. Rueda | Manuel Rueda
[1] Gerard J Kleywegt,et al. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. , 2003, Angewandte Chemie.
[2] Ruben Abagyan,et al. A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE) , 2008, J. Comput. Aided Mol. Des..
[3] Tom L. Blundell,et al. Keynote review: Structural biology and drug discovery , 2005 .
[4] Rommie E. Amaro,et al. An improved relaxed complex scheme for receptor flexibility in computer-aided drug design , 2008, J. Comput. Aided Mol. Des..
[5] Richard J. Hall,et al. Protein-Ligand Docking against Non-Native Protein Conformers , 2008, J. Chem. Inf. Model..
[6] R. Abagyan,et al. The flexible pocketome engine for structural chemogenomics. , 2009, Methods in molecular biology.
[7] G. Klebe. Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.
[8] Amy C Anderson,et al. Towards in silico lead optimization: Scores from ensembles of protein/ligand conformations reliably correlate with biological activity , 2006, Proteins.
[9] Paul N. Mortenson,et al. Diverse, high-quality test set for the validation of protein-ligand docking performance. , 2007, Journal of medicinal chemistry.
[10] T. A. Jones,et al. The Uppsala Electron-Density Server. , 2004, Acta crystallographica. Section D, Biological crystallography.
[11] Erin S. Bolstad,et al. In pursuit of virtual lead optimization: The role of the receptor structure and ensembles in accurate docking , 2008, Proteins.
[12] Ruben Abagyan,et al. Detailed ab initio prediction of lysozyme–antibody complex with 1.6 Å accuracy , 1994, Nature Structural Biology.
[13] R. Abagyan,et al. Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states. , 2008, Journal of medicinal chemistry.
[14] Thomas A. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[15] Claudio N. Cavasotto,et al. Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.
[16] Ruben Abagyan,et al. Consistent Improvement of Cross-Docking Results Using Binding Site Ensembles Generated with Elastic Network Normal Modes , 2009, J. Chem. Inf. Model..
[17] Somesh D. Sharma,et al. Managing protein flexibility in docking and its applications. , 2009, Drug discovery today.
[18] Pedro Alexandrino Fernandes,et al. Protein–ligand docking: Current status and future challenges , 2006, Proteins.
[19] Bernard Pirard,et al. Structure-based chemogenomics: analysis of protein family landscapes. , 2009, Methods in molecular biology.
[20] Holger Gohlke,et al. Target flexibility: an emerging consideration in drug discovery and design. , 2008, Journal of medicinal chemistry.
[21] Lisa M. Shewchuk,et al. Crystallization of protein–ligand complexes , 2006, Acta crystallographica. Section D, Biological crystallography.
[22] S. Teague. Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.
[23] Hao Wang,et al. Active Site Pressurization: A New Tool for Structure-Guided Drug Design and Other Studies of Protein Flexibility , 2008, J. Chem. Inf. Model..
[24] Marcel L. Verdonk,et al. Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase , 2002, J. Comput. Aided Mol. Des..
[25] Robin Taylor,et al. Comparing protein–ligand docking programs is difficult , 2005, Proteins.
[26] Alexander D. MacKerell,et al. Computational evaluation of protein-small molecule binding. , 2009, Current opinion in structural biology.
[27] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[28] R. Abagyan,et al. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.
[29] X. Barril,et al. Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. , 2005, Journal of medicinal chemistry.
[30] H. Scheraga,et al. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides , 1994 .
[31] B. Shoichet,et al. Soft docking and multiple receptor conformations in virtual screening. , 2004, Journal of medicinal chemistry.
[32] Ruben Abagyan,et al. Derivation of sensitive discrimination potential for virtual ligand screening , 1999, RECOMB.
[33] Ajay N. Jain. Bias, reporting, and sharing: computational evaluations of docking methods , 2008, J. Comput. Aided Mol. Des..
[34] Claudio N. Cavasotto,et al. Representing receptor flexibility in ligand docking through relevant normal modes. , 2005, Journal of the American Chemical Society.
[35] Ruben Abagyan,et al. Comparative study of several algorithms for flexible ligand docking , 2003, J. Comput. Aided Mol. Des..
[36] R. Abagyan,et al. Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes* , 2005, Molecular & Cellular Proteomics.
[37] H. Carlson. Protein flexibility and drug design: how to hit a moving target. , 2002, Current opinion in chemical biology.
[38] R. Abagyan,et al. Flexible ligand docking to multiple receptor conformations: a practical alternative. , 2008, Current opinion in structural biology.
[39] Charles L. Brooks,et al. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.
[40] P. Fischer,et al. Protein structures in virtual screening: a case study with CDK2. , 2006, Journal of medicinal chemistry.
[41] William J. Welsh,et al. Identification of a Minimal Subset of Receptor Conformations for Improved Multiple Conformation Docking and Two-Step Scoring , 2004, J. Chem. Inf. Model..
[42] B. Shoichet,et al. Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes. , 2003, Journal of medicinal chemistry.
[43] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[44] Reiji Teramoto,et al. Supervised Consensus Scoring for Docking and Virtual Screening , 2007, J. Chem. Inf. Model..
[45] Woody Sherman,et al. Improving database enrichment through ensemble docking , 2008, J. Comput. Aided Mol. Des..
[46] Ruben Abagyan,et al. Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking. , 2009, Journal of medicinal chemistry.